期刊文献+

洛阳市儿童医院多药耐药菌感染的分布及耐药性分析 被引量:3

Multidrug-resistant bacteria infections in children′s hospital of Luoyang and analysis of drug resistance
原文传递
导出
摘要 目的分析多药耐药菌分布、耐药性及易感因素,指导临床用药。方法对2010年度监测到的全院多药耐药菌及药敏结果进行分析,同时追踪其易感因素。结果共分离出病原菌1033株,其中多药耐药菌461株,检出率为44.6%;分离到的多药耐药菌主要为产ESBLs大肠埃希菌及耐甲氧西林凝固酶阴性葡萄球菌(MRCNS),分别占42.5%、26.2%;多药耐药菌对大多数常用抗菌药物耐药。结论结合医院药物敏感试验,婴幼儿革兰阴性多药耐药菌感染宜选用头孢哌酮/舒巴坦、亚胺培南;革兰阳性多药耐药菌感染宜选用夫西地酸、替考拉宁、万古霉素。 OBJECTIVE To analyze the distribution, drug resistance, and susceptible factors of multidrug-resistant organisms so as to guide the clinical treatment. METHODS The multidrug-resistant organisms monitored in 2010 and drug susceptibility testing were analyzed, at the same time the susceptible factors were tracked. RESULTS A total of 1033 strains were isolated, there were 461 strains of multidrug-resistant bacteria with the detection rate of 44.6% the multidrug-resistant bacteria isolated were mainly the ESBLs-produeing Escherichia coli and methicil- 1in-resistant coagulase-negative Staphylococcus, accounting %or 42. 5% and 26. 2% ; multidrug-resis%ant strains were resistant to common antibiotics. CONCLUSION According to the drug susceptibility testing, cefoperazone/ sulbactam and imipenem are suitable for the treatment of gram-negative multidrug-resistant organism infections in infants; fusidate, vancomycin, and teicoplanin are suitable for the treatment of gram-positive multidrug-resistant organism infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第15期3394-3395,3398,共3页 Chinese Journal of Nosocomiology
关键词 多药耐药菌 耐药性 分析 Multidrug-resistant organism Drug resistance Analysis
  • 相关文献

参考文献4

二级参考文献16

共引文献190

同被引文献31

  • 1糜祖煌.细菌抗菌药物耐药基因研究中值得注意的问题[J].世界感染杂志,2006,6(6):498-499. 被引量:23
  • 2郑望春,叶晓涛,黄衍锋.凝固酶阴性葡萄球菌致新生儿败血症的病原学及耐药性分析[J].中国热带医学,2007,7(10):1911-1912. 被引量:10
  • 3Dalgic N, Ceylan Y, Sancar M, et al. Successful treatment ofmuitidrug-resistant Acinetobacter baumanii ventriculitis with in-travenous and intraventricular colistin[J]. Ann Trop Paediatr,2009, 29(2): 141-147.
  • 4Suchada S. Klaita S S. Nuanchan P. et al. Multidrug-resistanthospital-associated infections in a pediatric intensive care unit: across-sectional survey in a Thai university hospitalQ]. Int J In-fect Dis, 2009, 13(4), 506-512.
  • 5iol C. Tubau F. Calatayud L. et al, Bacteraemia due tomultidrug-resistant Gram-negative bacilli in cancer patients: riskfactors, antibiotic therapy and outcomes[J]. J Antimicrob Che-mother, 2011, 66(3): 657-663.
  • 6Horasan E S, Ersoz G. Horoz M. et al. Risk factors for infec-tions caused by multidrug-resistant bacteria in patients with solidtumours[J]. Scand J Infect Dis* 2011,43(2) : 107-111.
  • 7Brian A, Sarah N, Bruce S, et al. Molecular and DescriptiveEpidemiology of Multidrug-Resistant Enterobacteriaceae in Hos-pitalized Infants[Jl. Infect Control Hosp Epidemiol, 2008,29(3): 250-255.
  • 8Aliberti S, Di Pasquale M, Zanaboni AM, etal. Stratifying riskfactors for multidrug-resistant pathogens in hospitalized patientscoming from the community with pneumonia [J]. Clin InfectDis, 2012, 54(4), 470-478.
  • 9Bayer M, Aslan G, Emekdas G. et al. Nasopharyngeal carriageof Streptococcus pneumoniae in healthy children and multidrugresistance[J]. Mikrobiyol Bui, 2008, 42(2) : 223-230.
  • 10王军,刘华,胡红兵,等.新生儿甲氧西林耐药凝固酶阴性葡萄球菌血液感染分离株耐药基因研究-第二届全国细菌耐药检测与临床专题学术会议[C].银川:宁夏人民出版社,2006.:202-203.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部